Fady Ibraham Malik
Director; EVP Research & Development · 16 filings · Latest: Oct 6, 2026
CYTOKINETICS INC
ROCKET PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CYTK | FADY MALIK | — | Sep 3, 2024 | Proposed Sale | $57.01 | 7,384 | $421.0K | — |
← Previous
Page 3 of 3